Global Reach and Expanding Indications Though currently approved for type 2 diabetes, Tirzepatide is undergoing additional studies for obesity treatment in non-diabetic individuals, as well as cardiovascular outcome trials
One of the major advantages of drug repositioning is that enormous data regarding the drugs pharmacokinetic properties and toxicities are often available, which reduces the need for extra studies
Nagata K, Horie T, Chohnabayashi N, Jinta T, Tsugitomi R, Shiraki A, et al
J Endocrinol 229:267275
To address this, key ingredients work together: Ashwagandha lowers stress hormones and improves sleep
Both drug classes are recognised in NICE guidance for type 2 diabetes management, though careful monitoring and patient education regarding side effects are essential